Welcome to LookChem.com Sign In|Join Free
  • or
Pyrrolo[1,2-c]pyrimidine derivatives, also known as 6-azaindolizine or 6-azapyrrocoline, have been explored as PI3Kα inhibitors, particularly in the context of cancer therapy. These compounds, when functionalized with a morpholine moiety, exhibit potential inhibitory activity against PI3Kα, a critical enzyme in oncogenic signaling pathways. Their design leverages pharmacophore models to enhance selectivity and binding affinity, with demonstrated cytotoxicity in cancer cell lines, suggesting their utility as targeted anticancer agents.

274-43-1

Post Buying Request

274-43-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

274-43-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 274-43-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 2,7 and 4 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 274-43:
(5*2)+(4*7)+(3*4)+(2*4)+(1*3)=61
61 % 10 = 1
So 274-43-1 is a valid CAS Registry Number.

274-43-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name pyrrolo[1,2-c]pyrimidine

1.2 Other means of identification

Product number -
Other names pyrrole<1,2-c>Pyrrolo<pyrimidin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:274-43-1 SDS

274-43-1Relevant academic research and scientific papers

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

Paragraph 0450, (2018/03/09)

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.

NEW CRTH2 ANTAGONISTS

-

Page/Page column 131-132, (2013/03/26)

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

New CRTh2 antagonists

-

Paragraph 0674-0677, (2013/03/26)

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

Derivatives of variolin b

-

, (2008/06/13)

The invention provides antitumour compounds of formula (I), wherein R1 is an aromatic substituent; R2 is hydrogen or a substituent when the dotted line is absent, or R2 is absent when the dotted line represents a bond to give a double bond between the nitrogen which bears R2 and the carbon which bears R3; R3 is an oxo group ═O when the dotted line is absent or is a substituent when the dotted line represents a bond to give a double bond between the nitrogen bearing R2 and the carbon bearing R3; R4 is hydrogen or a substituent; and pharmaceutically acceptable salts thereof.

Pyrrolodiazines. 5. Synthesis, structure, and chemistry of pyrrolo[1,2- c]pyrimidine. Dipolar cycloaddition of pyrrolo[1,2-c]pyrimidinium ylides

Minguez, Jose M.,Vaquero, Juan J.,Alvarez-Builla, Julio,Castano, Obis,Andres, Jose L.

, p. 7788 - 7801 (2007/10/03)

An improved synthesis of pyrrolo[1,2-c]pyrimidines, including the parent system, was accomplished via sequential condensation of substituted pyrrole- 2-carboxaldehydes with tosylmethyl isocyanide (TOSMIC), followed by desulfonylation of the formed tosylpyrrolo[1,2-c]pyrimidines. Based on the ab initio calculations performed on the pyrrolo[1,2-c]pyrimidine 1a, some of the basic chemistry was investigated, including electrophilic substitution, addition of organolithium reagents, metalation with lithium diisopropylamide (LDA) and subsequent reaction with electrophiles, and formation of salts by quaternization of the nonbridgehead nitrogen. Azomethine ylides generated from pyrrolo[1,2-c]pyrimidinium salts undergo 1,3-dipolar cycloaddition with suitable dipolarophiles to give new dipyrrolo[1,2-a;1',2'-c]pyrimidine derivatives, with high regio- and stereoselectivity.

Improved synthesis of pyrrolo[1,2-c]pyrimidine and derivatives

Minguez, Jose M.,Vaquero, Juan J.,Garcia-Navio, Jose L.,Alvarez-Builla, Julio

, p. 4263 - 4266 (2007/10/03)

An improved synthesis of pyrrolo[1,2-c]pyrimidine derivatives by cyclocondensation of pyrrole-2-carboxaldehydes with tosylmethyl isocyanide followed by desulfonylation of the resulting 2-tosylpyrrolo[1,2-c]- pyrimidines with sodium amalgam is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 274-43-1